Prior Auth Required

0048U - tissue, report of clinically significant mutation(s)

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicetissue, report of clinically significant mutation(s)
Procedure / Service Description

Cerebral Perfusion Anaysis, Ct W/Contrst, Postprocess, Determ Cerebral Blood Flow/Vol & - cancer-associated genes, including interrogation for somatic mutations and microsatellite instability, matched with normal specimens, utilizing formalin-fixed paraffin-embedded tumor 0048U tissue, report of clinically significant mutation(s) 0049U NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, quantitative Targeted genomic sequence analysis panel, acute myelogenous leukemia, DNA analysis, 194

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.